Literature DB >> 7086959

Transcription of the hepatitis B surface antigen gene in mouse cells transformed with cloned viral DNA.

C Pourcel, A Louise, M Gervais, N Chenciner, M F Dubois, P Tiollais.   

Abstract

Mouse L cells transformed with recombinant plasmids carrying hepatitis B virus (HBV) DNA fragments were used to study the transcription of the viral surface antigen gene (gene S). An HBV-specific, polyadenylated, 2.3-kilobase RNA was mapped on the HBV genome. This RNA hybridized with approximately 75% of the genome and excluded the region of the HBV core antigen gene (gene C). The 2.3-kilobase RNA species was present only in cell lines that produced hepatitis B surface antigen. An HBV-specific 2.3-kilobase RNA was also detected in human hepatoma cell line PLC/PRF/5 which produced hepatitis B surface antigen. A study of gene S expression in the transformed mouse L cells allowed us to localize the regions of initiation and termination of gene S transcription. Our results strongly suggest that the 2.3-kilobase RNA molecule is the mRNA of the major polypeptide of the envelope, which carries the viral surface antigen determinants.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7086959      PMCID: PMC256049          DOI: 10.1128/JVI.42.1.100-105.1982

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Intragenic DNA spacers interrupt the ovalbumin gene.

Authors:  R Weinstock; R Sweet; M Weiss; H Cedar; R Axel
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

3.  Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate.

Authors:  G M Wahl; M Stern; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

5.  Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line.

Authors:  P R Chakraborty; N Ruiz-Opazo; D Shouval; D A Shafritz
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

6.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

7.  Cloning of the active thymidine kinase gene of herpes simplex virus type 1 in Escherichia coli K-12.

Authors:  F Colbere-Garapin; S Chousterman; F Horodniceanu; P Kourilsky; A C Garapin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

8.  Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma.

Authors:  C Brechot; C Pourcel; A Louise; B Rain; P Tiollais
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

9.  Integration of hepatitis B virus sequences and their expression in a human hepatoma cell.

Authors:  J C Edman; P Gray; P Valenzuela; L B Rall; W J Rutter
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

10.  Establishment of a continuously growing cell line from primary carcinoma of the liver.

Authors:  J J Alexander; E M Bey; E W Geddes; G Lecatsas
Journal:  S Afr Med J       Date:  1976-12-18
View more
  56 in total

1.  trans-activation of viral enhancers by the hepatitis B virus X protein.

Authors:  D F Spandau; C H Lee
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

2.  Diversity of hepatitis B virus X gene-related transcripts in hepatocellular carcinoma: a novel polyadenylation site on viral DNA.

Authors:  C Hilger; I Velhagen; H Zentgraf; C H Schröder
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Complex regulation of transcription from the hepatitis B virus major surface antigen promoter in human hepatoma cell lines.

Authors:  A K Raney; D R Milich; A McLachlan
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  Identification of hepatitis B virus polypeptides encoded by the entire pre-s open reading frame.

Authors:  D T Wong; N Nath; J J Sninsky
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

5.  The enhancer sequence of human hepatitis B virus can enhance the activity of its surface gene promoter.

Authors:  H K Chang; C K Chou; C Chang; T S Su; C Hu; M Yoshida; L P Ting
Journal:  Nucleic Acids Res       Date:  1987-03-11       Impact factor: 16.971

6.  Replicative intermediate of hepatitis B virus in transfected murine fibroblasts.

Authors:  A Z Zelent; M A Sells; M Shvartsman; P M Price; G Acs
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

7.  Expression of hepatitis B antigens with a simian virus 40 vector.

Authors:  H Will; R Cattaneo; E Pfaff; C Kuhn; M Roggendorf; H Schaller
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

8.  Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.

Authors:  E Paoletti; B R Lipinskas; C Samsonoff; S Mercer; D Panicali
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

9.  Cloning and analysis of integrated hepatitis virus sequences from a human hepatoma cell line.

Authors:  Y Shaul; M Ziemer; P D Garcia; R Crawford; H Hsu; P Valenzuela; W J Rutter
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

10.  Plasmid-directed synthesis of hepatitis B surface antigen in monkey cells.

Authors:  C W Crowley; C C Liu; A D Levinson
Journal:  Mol Cell Biol       Date:  1983-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.